Business Context and Reporting Period
Rapid Micro Biosystems, Inc. (RPID) filed this Form 8-K on September 26, 2023, to report a resolution regarding its listing status on The Nasdaq Global Select Market.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock price.
Material Changes
The Company previously received notice on September 13, 2023, of non-compliance with Nasdaq Listing Rule 5550(a)(2) due to its Class A common stock closing below $1.00 per share for 30 consecutive business days (July 31, 2023, through September 11, 2023). As of September 26, 2023, the Company regained compliance after the stock closed at or above $1.00 per share for 10 consecutive business days (September 12, 2023, through September 25, 2023). The matter is now closed.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of risks beyond the resolved listing deficiency. No unusual items or contingencies were reported in this document.
Investor Verification Checklist
- Verify the current trading price of RPID to ensure it remains above the $1.00 minimum bid price threshold.
- Confirm the Company's continued compliance with other Nasdaq listing requirements (e.g., shareholder equity, market value of listed securities).
- Review subsequent filings for any new notices regarding stock price compliance.